Skip to content

About Us
Contact Us
News & Events

AIR Technology
ZIVA™ Platform
Fixed Assays
Custom Assays
Resources
- Publications and Downloads
- COVID-19 Research

AIR Technology
ZIVA™ Platform
Fixed Assays
Custom Assays
Resources
- Publications and Downloads
- COVID-19 Research

Previous

Next

St. Louis Business Journal: RiverVest leads $17M investment in Adarza, brings on new president

RiverVest leads $17 million investment in Adarza, brings on new president

READ MORE

Supply Chain Manager

September 28, 2020

Using lasers to paint a high-definition picture of the body’s COVID-19 immune response

August 14, 2020

Adarza Shifts Focus to SARS-CoV-2 in Anticipation of Protein Biosensor Launch

August 14, 2020

Adarza’s Ziva provides window into immune response to COVID-19 and other pathogens

June 24, 2020

St. Louis biotech startup raises $25M as it prepares for commercialization

February 6, 2020

Adarza raises $25 million, moves toward commercialization

February 5, 2020

NAVIGATE

AIR Technology
ZIVA Platform
Custom Assays
Publications and Downloads
COVID-19 Research
Contact Us

Menu

AIR Technology
ZIVA Platform
Custom Assays
Publications and Downloads
COVID-19 Research
Contact Us

READ THE LATEST

Supply Chain Manager

Using lasers to paint a high-definition picture of the body’s COVID-19 immune response

Adarza Shifts Focus to SARS-CoV-2 in Anticipation of Protein Biosensor Launch

JOIN OUR LIST

First Name *

Last Name *

Email *

Company

Website

Copyright © 2021 Adarza BioSystems
All Rights Reserved | ADARZA BIOSYSTEMS is a registered trademark of Adarza Biosystems, Inc.